Evidence map›Paper›PMID 23943690›Full record

ArticleJournal of ophthalmic & vision research2013

Advances in retinal stem cell biology.

Andrea S Viczian

Open access · greenAbstract read
In one paragraph

Article in Journal of ophthalmic & vision research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. V-ATPase Regulates Retinal Progenitor Cell Proliferation During Eye Regrowth inJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Stem cell therapy for retinal diseases.World journal of stem cells · 2015
    Review
  7. Review
  8. A novel method for inducing nerve growth via modulation of host resting potential: gap junction-mediated and serotonergic signaling mechanisms.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2015
    Article
  9. Review
  10. Article
  11. Putting regeneration into regenerative medicine.Journal of ophthalmic & vision research · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Andrea S ViczianDepartment of Ophthalmology, Center for Vision Research, SUNY Eye Institute, Upstate Medical University Syracuse, NY, USA.
SUNY Upstate Medical University · US

Funding

Retinal Progenitors for Vision RescueR01EY019517 · NEI · UPSTATE MEDICAL UNIVERSITY · PI VICZIAN, ANDREA S · 2011 to 2014
$1.4M
NEI NIH HHS R01 EY019517
6 · The paper itself

Abstract

Tremendous progress has been made in recent years to generate retinal cells from pluripotent cell sources. These advances provide hope for those suffering from blindness due to lost retinal cells. Understanding the intrinsic genetic network in model organisms, like fly and frog, has led to a better understanding of the extrinsic signaling pathways necessary for retinal progenitor cell formation in mouse and human cell cultures. This review focuses on the culture methods used by different groups, which has culminated in the generation of laminated retinal tissue from both embryonic and induced pluripotent cells. The review also briefly describes advances made in transplantation studies using donor retinal progenitor and cultured retinal cells.

Indexed as

Artificial RetinaCone PhotoreceptorsEmbryonic Stem Cells, ESEyeGanglion CellsGenetic NetworkInduced Pluripotent Stem Cells, iPSNogginRetinaSignaling PathwaysStromal Cells

Identifiers

PMID23943690
PMCPMC3740467
OpenAlexW1707989573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.